Experimental therapy with progesterone on a mouse model for hereditary neuropathy with liability to pressure palsies (HNPP)

Hereditary neuropathy with liability to pressure palsies (HNPP) is an autosomal dominant demyelinating disorder characterized by episodic, recurrent peripheral sensory and motor neuropathies, triggered by minor traumas or compression in various locations. A typical clinical manifestation of HNPP is...

Full description

Bibliographic Details
Main Author: Granat, Heidi Pauliina
Other Authors: Sereda, Michael Werner Prof. Dr., Müller, Michael Prof. Dr.
Format: Doctoral or Postdoctoral Thesis
Language:English
Published: 2020
Subjects:
610
DML
Online Access:http://hdl.handle.net/21.11130/00-1735-0000-0005-1341-C
https://doi.org/10.53846/goediss-7866
https://nbn-resolving.org/urn:nbn:de:gbv:7-21.11130/00-1735-0000-0005-1341-C-1
id ftsubgoettdiss:oai:ediss.uni-goettingen.de:21.11130/00-1735-0000-0005-1341-C
record_format openpolar
spelling ftsubgoettdiss:oai:ediss.uni-goettingen.de:21.11130/00-1735-0000-0005-1341-C 2023-09-05T13:19:07+02:00 Experimental therapy with progesterone on a mouse model for hereditary neuropathy with liability to pressure palsies (HNPP) Granat, Heidi Pauliina Sereda, Michael Werner Prof. Dr. Müller, Michael Prof. Dr. 2020-02-26 http://hdl.handle.net/21.11130/00-1735-0000-0005-1341-C https://doi.org/10.53846/goediss-7866 https://nbn-resolving.org/urn:nbn:de:gbv:7-21.11130/00-1735-0000-0005-1341-C-1 eng eng http://hdl.handle.net/21.11130/00-1735-0000-0005-1341-C http://dx.doi.org/10.53846/goediss-7866 urn:nbn:de:gbv:7-21.11130/00-1735-0000-0005-1341-C-1 1691125164 http://creativecommons.org/licenses/by-nc-nd/4.0/ 610 HNPP Progesterone Neuropathy Medizin (PPN619874732) Neurologie - Allgemein- und Gesamtdarstellungen (PPN619876247) doctoralThesis 2020 ftsubgoettdiss https://doi.org/10.53846/goediss-7866 2023-08-18T08:31:24Z Hereditary neuropathy with liability to pressure palsies (HNPP) is an autosomal dominant demyelinating disorder characterized by episodic, recurrent peripheral sensory and motor neuropathies, triggered by minor traumas or compression in various locations. A typical clinical manifestation of HNPP is acute, painless, recurrent peripheral nerve palsies. The symptoms are brief and improve generally within days, weeks or months, with full recovery occurring in 50 % of episodes. The affected limbs usually show significant slowing and conduction blocks (CB) in nerve conduction velocity (NCV) studies, distal motor latencies (DML) are increased and sensory nerve conduction velocities are often decreased. In addition, sensory nerve action potential amplitudes are reduced. Only symptomatic treatment is currently available. The majority of cases of HNPP can be attributed to a heterozygous 1.5 Mb deletion on chromosome 17p11.2 that includes the peripheral myelin protein 22 (PMP22) gene. PMP22 is an intrinsic membrane protein, primarily expressed in myelinating Schwann cells. PMP22 comprises approximately 2-5 % of total myelin protein and is largely confined to compact myelin. Its precise biological functions are still unknown but it has been proposed to serve as a structural component of myelin, required for the flawless development of peripheral nerves, axon maintenance, myelin formation and the determination of myelin thickness and stability. The histological characteristics of HNPP nerves consist of focal excessive myelin folds (tomacula), characterized by an extremely thickened myelin sheath wrapping around an axon of reduced diameter, and onion bulbs. Tomacula may initially arise from myelin invaginations. The signaling pathway of progesterone is known to regulate the mRNA expression of myelin genes in the peripheral nervous system. In the present study subcutaneous application of progesterone for a period of two months increased the Pmp22 expression in the HNPP mice (Pmp22+/-) to wild type levels. The expression of ... Doctoral or Postdoctoral Thesis DML Georg-August-Universität Göttingen: eDiss
institution Open Polar
collection Georg-August-Universität Göttingen: eDiss
op_collection_id ftsubgoettdiss
language English
topic 610
HNPP
Progesterone
Neuropathy
Medizin (PPN619874732)
Neurologie - Allgemein- und Gesamtdarstellungen (PPN619876247)
spellingShingle 610
HNPP
Progesterone
Neuropathy
Medizin (PPN619874732)
Neurologie - Allgemein- und Gesamtdarstellungen (PPN619876247)
Granat, Heidi Pauliina
Experimental therapy with progesterone on a mouse model for hereditary neuropathy with liability to pressure palsies (HNPP)
topic_facet 610
HNPP
Progesterone
Neuropathy
Medizin (PPN619874732)
Neurologie - Allgemein- und Gesamtdarstellungen (PPN619876247)
description Hereditary neuropathy with liability to pressure palsies (HNPP) is an autosomal dominant demyelinating disorder characterized by episodic, recurrent peripheral sensory and motor neuropathies, triggered by minor traumas or compression in various locations. A typical clinical manifestation of HNPP is acute, painless, recurrent peripheral nerve palsies. The symptoms are brief and improve generally within days, weeks or months, with full recovery occurring in 50 % of episodes. The affected limbs usually show significant slowing and conduction blocks (CB) in nerve conduction velocity (NCV) studies, distal motor latencies (DML) are increased and sensory nerve conduction velocities are often decreased. In addition, sensory nerve action potential amplitudes are reduced. Only symptomatic treatment is currently available. The majority of cases of HNPP can be attributed to a heterozygous 1.5 Mb deletion on chromosome 17p11.2 that includes the peripheral myelin protein 22 (PMP22) gene. PMP22 is an intrinsic membrane protein, primarily expressed in myelinating Schwann cells. PMP22 comprises approximately 2-5 % of total myelin protein and is largely confined to compact myelin. Its precise biological functions are still unknown but it has been proposed to serve as a structural component of myelin, required for the flawless development of peripheral nerves, axon maintenance, myelin formation and the determination of myelin thickness and stability. The histological characteristics of HNPP nerves consist of focal excessive myelin folds (tomacula), characterized by an extremely thickened myelin sheath wrapping around an axon of reduced diameter, and onion bulbs. Tomacula may initially arise from myelin invaginations. The signaling pathway of progesterone is known to regulate the mRNA expression of myelin genes in the peripheral nervous system. In the present study subcutaneous application of progesterone for a period of two months increased the Pmp22 expression in the HNPP mice (Pmp22+/-) to wild type levels. The expression of ...
author2 Sereda, Michael Werner Prof. Dr.
Müller, Michael Prof. Dr.
format Doctoral or Postdoctoral Thesis
author Granat, Heidi Pauliina
author_facet Granat, Heidi Pauliina
author_sort Granat, Heidi Pauliina
title Experimental therapy with progesterone on a mouse model for hereditary neuropathy with liability to pressure palsies (HNPP)
title_short Experimental therapy with progesterone on a mouse model for hereditary neuropathy with liability to pressure palsies (HNPP)
title_full Experimental therapy with progesterone on a mouse model for hereditary neuropathy with liability to pressure palsies (HNPP)
title_fullStr Experimental therapy with progesterone on a mouse model for hereditary neuropathy with liability to pressure palsies (HNPP)
title_full_unstemmed Experimental therapy with progesterone on a mouse model for hereditary neuropathy with liability to pressure palsies (HNPP)
title_sort experimental therapy with progesterone on a mouse model for hereditary neuropathy with liability to pressure palsies (hnpp)
publishDate 2020
url http://hdl.handle.net/21.11130/00-1735-0000-0005-1341-C
https://doi.org/10.53846/goediss-7866
https://nbn-resolving.org/urn:nbn:de:gbv:7-21.11130/00-1735-0000-0005-1341-C-1
genre DML
genre_facet DML
op_relation http://hdl.handle.net/21.11130/00-1735-0000-0005-1341-C
http://dx.doi.org/10.53846/goediss-7866
urn:nbn:de:gbv:7-21.11130/00-1735-0000-0005-1341-C-1
1691125164
op_rights http://creativecommons.org/licenses/by-nc-nd/4.0/
op_doi https://doi.org/10.53846/goediss-7866
_version_ 1776199929974226944